BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Table 5 Cox proportional hazards regression analysis of prognostic factors in adenoid cystic carcinoma, hazard ratio (95%CI)
Variable
Univariate
P value
Multivariate
P value
Recurrence-free survival
Advanced T stage (T3 and T4 vs T1 and T2)3.89 (1.21-9.85)0.0213.46 (1.21-9.85)0.021
Positive margins (R1/R2 vs R0)2.84 (1.09-7.42)0.0322.84 (1.09-7.42)0.032
PNI (present vs absent)2.67 (1.01-7.09)0.0472.12 (0.91-6.03)0.081
PORT (yes vs no)0.57 (0.24-1.31)0.1820.57 (0.24-1.31)0.182
Overall survival
Advanced T stage (T3 and T4 vs T1 and T2)4.12 (1.39-12.20)0.0113.28 (1.18-9.11)0.023
Positive margins (R1/R2 vs R0)3.01 (1.08-8.39)0.0352.71 (1.01-7.29)0.048
PNI (present vs absent)2.74 (1.02-7.35)0.0442.31 (0.89-6.04)0.075
PORT (yes vs no)0.49 (0.21-1.12)0.0940.52 (0.24-1.15)0.096


Write to the Help Desk